AzTrials
AzTrials

End-stage Liver DiseaseLTx-outflowNCT01707810

Prospective Trial Comparing Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver

A study testing Piggyback method and conventional method in people with End-stage Liver Disease, run by University of Sao Paulo.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

METHODS: Patients were submitted to conventional (n=15) or piggyback (n=17) liver transplantation (LTx). Free hepatic vein pressure (FHVP) and the central venous pressure (CVP) measurements were performed after graft reperfusion. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
End-stage Liver Disease
What is being tested?
Piggyback method and conventional method
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
No sites listed yet
Study dates
Oct 1999to Oct 2000
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Inclusion criteria admitted of both genders, aged 18 years or older, submitted to a first elective LTx, with no clinical or technical reasons justifying a preferential option by conventional or piggyback method

Who cannot join

  • patients submitted to living donor LTx, in whom IVC is routinely preserved and those with familial amyloidotic polyneuropathy, whom, in our routine, are routinely submitted to conventional LTx.

About this study

Official title: Prospective Randomized Trial Comparing the Clinical Efficiency of Conventional Versus Piggyback Method in Venous Drainage of the Transplanted Liver

METHODS: Patients were submitted to conventional (n=15) or piggyback (n=17) liver transplantation (LTx). Free hepatic vein pressure (FHVP) and the central venous pressure (CVP) measurements were performed after graft reperfusion. Postoperative (PO) serum creatinine (Cr) was measured, acute renal failure (ARF) was defined as Cr > or = 2,0mg/dL and PO renal function was analyzed by modificated RIFLE-AKIN. PO overall Cr was calculated by area under the curve (AUC) of Cr vs. time. on the first week.

Read the detailed description

Thirty-two patients recruited among liver transplant recipients submitted to surgery at the Liver Unit at the Hospital das Clínicas of the University of São Paulo Medical School between 8 th October, 1999 and 30 rd September, 2000 were studied. The patients were assigned by randomization to two groups: transplant performed using the conventional or the piggyback method. These patients are part of a larger clinical trial where pulmonary alterations are compared between patients operated using the conventional method with venovenous bypass and the piggyback method.(10) Inclusion criteria admitted of both genders, aged 18 years or older, submitted to a first elective LTx, with no clinical or technical reasons justifying a preferential option by conventional or piggyback method. For this reason, we excluded patients submitted to living donor LTx, in whom IVC is routinely preserved and those with familial amyloidotic polyneuropathy, whom, in our routine, are routinely submitted to conventional LTx.

The randomization process was performed by a team of nurses not involved with the intraoperative care of the patients. This was obtained by "coin-tossing". In each case, randomization was paired according to the Child-Pugh's Score, calculated immediately before surgery. Stratification was performed by blocking randomization in each subset of patient (scores A, B, or C), with blocks of size 2 with a one-to-one allocation ratio. Thus, while the first patient of each Child-Pugh score was effectively randomized, the second was automatically allocated to the opposite surgical method, completing a pair. However, the investigators had no influence on the second recipient selection due to the characteristics of the organ allocation system in Brazil, former MELD scale criteria was introduced. In that time, the graft distribution was according to four distinct blood groups (A,B,AB,O) generated a greater obstacle to predicting who would be the next patient as related to what would be obtained if blocks of 4 size have been used.

Surgeries of donor and of recipient were performed with small adaptations in the usual technique in order to evaluate the pressure gradient between the hepatic vein and the right atrium in the two groups. In the conventional method IVC was clamped during the anhepatic phase and venous return was maintained by a portal femoral axillary venovenous bypass with a centrifugal pump. In these cases, IVC reconstruction was performed by end-to-end anastomosis above and below the liver. In the piggyback method IVC was not clamped in any case. Implantation method of the grafted IVC in recipient IVC was not standardized, being defined by the responsible surgeon during the procedure. In the two groups, all patients were submitted to simultaneous arterial and portal revascularization, according to the routine of the service.

Free hepatic vein pressure (FHVP) was measured using an 8F polyethylene catheter with a multiperforated distal end, which was positioned in the graft's right hepatic vein during ex situ preparation on the back table. The proximal end of this catheter was exteriorized in the infrahepatic portion of IVC. In the conventional group, exteriorization was performed through the anastomosis suture. In the piggyback group, IVC was ligated around the catheter. Central venous pressure (CVP) was obtained using a Swan-Ganz catheter (routine procedure). Measurement of hepatic vein and right atrium pressure was made once, after concluding biliary anastomosis.

All measurements were obtained with the same transducer, determining as zero reference level the median axillary line. Pressure measurement was performed in apnea in order to avoid that the patient's respiratory incursions would determine oscillations in the pressure curve. When oscillations persisted in spite of this maneuver, the arithmetic mean of the observed maximum and minimum values was recorded. "hepatic venous block" was considered when a pressure gradient higher than 3 mm Hg was present.(4) Serum creatinine (Cr) was determined in the preoperatory period (immediately before surgery), on postoperative days (PO) 1 to 7 and on 14, 21 and 28. Occurrence of acute renal failure (ARF) was defined as postoperative creatinine peak > or = 2.0. (8) For each case, the area under the curve (AUC) Cr vs. time, calculated by the trapezoidal method (11) and divided by the postoperative observation time (28 days), was used as a postoperative overall creatinine parameter. Each group, conventional and piggyback, are also analyzed according to the RIFLE which classifies ARF in three grades of increasing severity: risk (class R), injury (class I) and failure (class F) - and two outcome classes - loss and end-stage kidney disease. RIFLE classification provides these grades based on changes in either Cr or urine output from the baseline condition. The RIFLE criteria is an important tool to help the international community compare data on ARF and was validated elsewhere (12, 13), being modified in 2005 as RIFLE-AKIN (14). For statistical analysis, in this study, the Class R are unified with the group of patients without renal injuries (considered as nule alterations), and the patients with class I and F were unified. The outcome classes are late consequences of the LTx and were not studied in the present clinical trial.

Postoperative massive ascites was considered as abdominal fluid accumulation with a volume over 500 ml/day for more than 30 days (6) evaluated through body weight, abdominal drain output or paracentesis.

The patients were followed up until 30 rd June, 2006, recording the date of death of those who died.

Being tested
Piggyback method, conventional method
Keywords
Liver transplatation
Medical subject headings
End Stage Liver Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Piggyback methodProcedure or surgery

    Also called Liver transplantaton piggyback method

    In the piggyback method IVC was not clamped in any case. Implantation method of the grafted IVC in recipient IVC was not standardized, being defined by the responsible surgeon during the procedure. In the two groups, all patients were submitted to simultaneous arterial and portal revascularization, according to the routine of the service.

  • conventional methodProcedure or surgery

Study groups in NCT01707810
Study groupRoleWhat they receive
Conventional methodSham comparatorIn the conventional method IVC was clamped during the anhepatic phase and venous return was maintained by a portal femoral axillary venovenous bypass with a centrifugal pump. In these cases, IVC reconstruction was performed by end-to-end anastomosis above and below the liver.
Receives: Procedure: conventional method
Piggyback methodExperimentalIn the piggyback method IVC was not clamped in any case. Implantation method of the grafted IVC in recipient IVC was not standardized, being defined by the responsible surgeon during the procedure. In the two groups, all patients were submitted to simultaneous arterial and portal revascularization, according to the routine of the service.
Receives: Procedure: Piggyback method

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hepatic vein and right atrium pressure measurements (observed FHPV-CVP gradient values)

    Free hepatic vein pressure (FHVP) was measured using an 8F polyethylene catheter with a multiperforated distal end, which was positioned in the graft's right hepatic vein during ex situ preparation on the back table. The proximal end of this catheter was exteriorized in the infrahepatic portion of IVC. In the conventional group, exteriorization was performed through the anastomosis suture. In the piggyback group, IVC was ligated around the catheter. Central venous pressure (CVP) was obtained using a Swan-Ganz catheter (routine procedure). Measurement of hepatic vein and right atrium pressure was made once, after concluding biliary anastomosis.

    Measured: intraoperatory

Secondary outcomes (1)
  1. Serum Creatinine

    Serum creatinine (Cr) was determined in the preoperatory period (immediately before surgery), on postoperative days (PO) 1 to 7 and on 14, 21 and 28. Occurrence of acute renal failure (ARF) was defined as postoperative creatinine peak > or = 2.0

    Measured: postoperative days (PO) 1 to 7 and on 14, 21 and 28

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2012 (estimated)
  2. Study startOct 1999
  3. Primary completionSep 2000
  4. Study completionOct 2000

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01707810
Sponsor's protocol ID
LIVER TRANSPLANT OUTFLOW
Acronym
LTx-outflow
Status last verified
Oct 2012
First submitted
12 Oct 2012
Last updated
16 Oct 2012
Results posted
No
Data monitoring committee
No

Publications

  • Brescia MD, Massarollo PC, Imakuma ES, Mies S. Prospective Randomized Trial Comparing Hepatic Venous Outflow and Renal Function after Conventional versus Piggyback Liver Transplantation. PLoS One. 2015 Jun 26;10(6):e0129923. doi: 10.1371/journal.pone.0129923. eCollection 2015.

    PubMed 26115520

Questions about this trial

What is this clinical trial studying?

A study testing Piggyback method and conventional method in people with End-stage Liver Disease, run by University of Sao Paulo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hepatic vein and right atrium pressure measurements (observed FHPV-CVP gradient values) (time frame: intraoperatory). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01707810, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in